PeptiDream, Ipsen Widen Research Pact To Cover Endocrinoligic Diseases
This article was originally published in PharmAsia News
Executive Summary
PeptiDream and Ipsen have agreed to expand their six-month-old research collaboration to cover discovery-to-market therapeutic peptides for serious medical conditions.